{"success":true,"data":{"pressRelease":{"id":"126342","rtpr_id":"nGNX4lSclY","ticker":"FULC","exchange":"NASDAQ","all_tickers":["FULC","IRDM","TECH","WEAV"],"title":"Halper Sadeh LLC is Investigating Whether WEAV, FULC, IRDM, TECH are Obtaining Fair Deals for their Shareholders","author":"Globe Newswire","published_at":"2026-08-24T19:10:38.104Z","article_body":"Insiders may stand to receive substantial financial benefits not available to\nordinary shareholders.\n\nThe proposed transactions may contain terms that could limit superior\ncompeting offers.\n\nShareholders are encouraged to contact the firm to discuss their rights and\noptions at no cost or obligation. We would handle any matter on a contingent\nfee basis, whereby you would not be responsible for out-of-pocket payment of\nour legal fees or expenses.\n\nNEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor\nrights law firm, is investigating the following companies for potential\nviolations of the federal securities laws and/or breaches of fiduciary duties\nto shareholders relating to:\n\nWeave Communications, Inc. (NYSE: WEAV)’s sale to Francisco Partners for\n$7.40 per share in cash. If you are a Weave shareholder, click here to learn\nmore about your legal rights and options\n(https://www.globenewswire.com/Tracker?data=r6nOrngfTL6vt1Kmp7l7HPSfFe5RQjPUDn5ATg5a1gfHES4usoAEhR7X2-WDWwNoahstGN8ErT-TXCJDA85qDDEmMsy2U1ciQdOZje0E37ZjIx8tS-n8ITI49lPS3jVQNxHXu3CLTY_W7EAFuvCLPpZZPPMOnUqvpjkpPmi88Nwmyez-vtA_OaqYT4RN_ifO).\n\nFulcrum Therapeutics, Inc. (NASDAQ: FULC)’s merger with Slate Medicines,\nInc. Upon closing of the proposed transaction, Fulcrum shareholders are\nexpected to own 5.0% of the combined company. If you are a Fulcrum\nshareholder, click here to learn more about your rights and options\n(https://www.globenewswire.com/Tracker?data=r6nOrngfTL6vt1Kmp7l7HPSfFe5RQjPUDn5ATg5a1ge6xSJFTKmSxL-r9yjOD6EKNmp7Vn12QezgjuK3tW0lkriTMxvxDecqkq-dRj09EQRcdKqmwe9e7ywwSvIe-8Lp6vYHco90O_FzsSZRS5naq5n9rOr0PnBXalV-abKfYY22GXmQjvPPPtnWtslr7F8J).\n\nIridium Communications Inc. (NASDAQ: IRDM)’s sale to Rocket Lab Corporation\nfor $27.00 in cash and a number of shares of Rocket Lab common stock\ncalculated pursuant to an exchange ratio for each share of Iridium. If you are\nan Iridium shareholder, click here to learn more about your rights and options\n(https://www.globenewswire.com/Tracker?data=r6nOrngfTL6vt1Kmp7l7HPSfFe5RQjPUDn5ATg5a1ge6xSJFTKmSxL-r9yjOD6EKNmp7Vn12QezgjuK3tW0lkv0gsXpWBhdEbUVqQh-bn0WrEyxj78tYmxbCbJEbAxKor9rLUyN7zHQV_hiF4DDhQRPkhdEc_tVdbgXmCHkUbMgJngQFQ0jvD-TIS_lZz2GD).\n\nBio-Techne Corporation (NASDAQ: TECH)’s sale to Merck KGaA for $73.00 per\nshare in cash. If you are a Bio-Techne shareholder, click here to learn more\nabout your rights and options\n(https://www.globenewswire.com/Tracker?data=r6nOrngfTL6vt1Kmp7l7HPSfFe5RQjPUDn5ATg5a1ge6xSJFTKmSxL-r9yjOD6EKNmp7Vn12QezgjuK3tW0lkkQcMAv_-Y8bf44mpFELZBOC_8bJldgpVCwdfI5wpsywfh2fEIojB7KwdylDtwjiJR5xpxyJKxpLANIKlF2VqE69OfSTgskq9J2R1RrXLGD5).\n\nOn behalf of shareholders, Halper Sadeh LLC may seek increased consideration,\nadditional disclosures and information, or other relief and benefits.\n\nHalper Sadeh LLC represents investors all over the world who have fallen\nvictim to securities fraud and corporate misconduct. Our attorneys have been\ninstrumental in implementing corporate reforms and recovering millions of\ndollars on behalf of defrauded investors.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\nContact Information:\nHalper Sadeh LLC\nDaniel Sadeh, Esq.\nZachary Halper, Esq.\nOne World Trade Center\n85th Floor\nNew York, NY 10007\n(212) 763-0060\nsadeh@halpersadeh.com\nzhalper@halpersadeh.com   \nhttps://www.halpersadeh.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX4lSclY","title":"Halper Sadeh LLC is Investigating Whether WEAV, FULC, IRDM, TECH are Obtaining Fair Deals for their Shareholders","author":"Globe Newswire","ticker":"FULC","created":"2026-08-24T19:10:38.104Z","tickers":["FULC","IRDM","TECH","WEAV"],"exchange":"NASDAQ","article_body":"Insiders may stand to receive substantial financial benefits not available to\nordinary shareholders.\n\nThe proposed transactions may contain terms that could limit superior\ncompeting offers.\n\nShareholders are encouraged to contact the firm to discuss their rights and\noptions at no cost or obligation. We would handle any matter on a contingent\nfee basis, whereby you would not be responsible for out-of-pocket payment of\nour legal fees or expenses.\n\nNEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor\nrights law firm, is investigating the following companies for potential\nviolations of the federal securities laws and/or breaches of fiduciary duties\nto shareholders relating to:\n\nWeave Communications, Inc. (NYSE: WEAV)’s sale to Francisco Partners for\n$7.40 per share in cash. If you are a Weave shareholder, click here to learn\nmore about your legal rights and options\n(https://www.globenewswire.com/Tracker?data=r6nOrngfTL6vt1Kmp7l7HPSfFe5RQjPUDn5ATg5a1gfHES4usoAEhR7X2-WDWwNoahstGN8ErT-TXCJDA85qDDEmMsy2U1ciQdOZje0E37ZjIx8tS-n8ITI49lPS3jVQNxHXu3CLTY_W7EAFuvCLPpZZPPMOnUqvpjkpPmi88Nwmyez-vtA_OaqYT4RN_ifO).\n\nFulcrum Therapeutics, Inc. (NASDAQ: FULC)’s merger with Slate Medicines,\nInc. Upon closing of the proposed transaction, Fulcrum shareholders are\nexpected to own 5.0% of the combined company. If you are a Fulcrum\nshareholder, click here to learn more about your rights and options\n(https://www.globenewswire.com/Tracker?data=r6nOrngfTL6vt1Kmp7l7HPSfFe5RQjPUDn5ATg5a1ge6xSJFTKmSxL-r9yjOD6EKNmp7Vn12QezgjuK3tW0lkriTMxvxDecqkq-dRj09EQRcdKqmwe9e7ywwSvIe-8Lp6vYHco90O_FzsSZRS5naq5n9rOr0PnBXalV-abKfYY22GXmQjvPPPtnWtslr7F8J).\n\nIridium Communications Inc. (NASDAQ: IRDM)’s sale to Rocket Lab Corporation\nfor $27.00 in cash and a number of shares of Rocket Lab common stock\ncalculated pursuant to an exchange ratio for each share of Iridium. If you are\nan Iridium shareholder, click here to learn more about your rights and options\n(https://www.globenewswire.com/Tracker?data=r6nOrngfTL6vt1Kmp7l7HPSfFe5RQjPUDn5ATg5a1ge6xSJFTKmSxL-r9yjOD6EKNmp7Vn12QezgjuK3tW0lkv0gsXpWBhdEbUVqQh-bn0WrEyxj78tYmxbCbJEbAxKor9rLUyN7zHQV_hiF4DDhQRPkhdEc_tVdbgXmCHkUbMgJngQFQ0jvD-TIS_lZz2GD).\n\nBio-Techne Corporation (NASDAQ: TECH)’s sale to Merck KGaA for $73.00 per\nshare in cash. If you are a Bio-Techne shareholder, click here to learn more\nabout your rights and options\n(https://www.globenewswire.com/Tracker?data=r6nOrngfTL6vt1Kmp7l7HPSfFe5RQjPUDn5ATg5a1ge6xSJFTKmSxL-r9yjOD6EKNmp7Vn12QezgjuK3tW0lkkQcMAv_-Y8bf44mpFELZBOC_8bJldgpVCwdfI5wpsywfh2fEIojB7KwdylDtwjiJR5xpxyJKxpLANIKlF2VqE69OfSTgskq9J2R1RrXLGD5).\n\nOn behalf of shareholders, Halper Sadeh LLC may seek increased consideration,\nadditional disclosures and information, or other relief and benefits.\n\nHalper Sadeh LLC represents investors all over the world who have fallen\nvictim to securities fraud and corporate misconduct. Our attorneys have been\ninstrumental in implementing corporate reforms and recovering millions of\ndollars on behalf of defrauded investors.\n\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n\nContact Information:\nHalper Sadeh LLC\nDaniel Sadeh, Esq.\nZachary Halper, Esq.\nOne World Trade Center\n85th Floor\nNew York, NY 10007\n(212) 763-0060\nsadeh@halpersadeh.com\nzhalper@halpersadeh.com   \nhttps://www.halpersadeh.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-08-24T19:10:38.137854643Z","server_sent_at_ms":1787598638137},"received_at":"2026-08-24T19:10:38.188Z","source_url":null},"analysis":{"id":"115283","press_release_id":"126342","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Halper Sadeh LLC is investigating Fulcrum Therapeutics regarding its proposed merger with Slate Medicines.\n\nCurrent terms indicate that Fulcrum shareholders are expected to own 5.0% of the combined company upon closing of the transaction.\n\nThe firm is soliciting investors to discuss potential breaches of fiduciary duty and to serve as lead plaintiffs on a contingency fee basis.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{"customDimensions":{"share_ownership_combined_company":"5.0%"}},"quotedText":"","namedEntities":{"people":[{"name":"Daniel Sadeh","role":"Attorney"},{"name":"Zachary Halper","role":"Attorney"}],"products":[],"companies":[{"name":"Halper Sadeh LLC","relationship":"plaintiff law firm"},{"name":"Slate Medicines, Inc.","relationship":"merger partner"},{"name":"Weave Communications, Inc.","ticker":"WEAV","relationship":"other investigation subject"},{"name":"Iridium Communications Inc.","ticker":"IRDM","relationship":"other investigation subject"},{"name":"Bio-Techne Corporation","ticker":"TECH","relationship":"other investigation subject"},{"name":"Francisco Partners","relationship":"acquirer"},{"name":"Rocket Lab Corporation","relationship":"acquirer"},{"name":"Merck KGaA","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$7.40","context":"per share cash offer for Weave Communications"},{"amount":"$27.00","context":"cash offer per share for Iridium Communications"},{"amount":"$73.00","context":"per share cash offer for Bio-Techne Corporation"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Halper Sadeh LLC. No new disclosure from the issuer; no certified class, no settlement. Boilerplate investigation announcement regarding the proposed merger."},"tickerRelevance":{"others":[{"ticker":"WEAV","relevance":"mentioned"},{"ticker":"IRDM","relevance":"mentioned"},{"ticker":"TECH","relevance":"mentioned"}],"primary":"FULC"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Halper Sadeh LLC is investigating Fulcrum Therapeutics regarding its proposed merger with Slate Medicines.\n\nCurrent terms indicate that Fulcrum shareholders are expected to own 5.0% of the combined company upon closing of the transaction.\n\nThe firm is soliciting investors to discuss potential breaches of fiduciary duty and to serve as lead plaintiffs on a contingency fee basis.","key_figures":{"customDimensions":{"share_ownership_combined_company":"5.0%"}},"named_entities":{"people":[{"name":"Daniel Sadeh","role":"Attorney"},{"name":"Zachary Halper","role":"Attorney"}],"products":[],"companies":[{"name":"Halper Sadeh LLC","relationship":"plaintiff law firm"},{"name":"Slate Medicines, Inc.","relationship":"merger partner"},{"name":"Weave Communications, Inc.","ticker":"WEAV","relationship":"other investigation subject"},{"name":"Iridium Communications Inc.","ticker":"IRDM","relationship":"other investigation subject"},{"name":"Bio-Techne Corporation","ticker":"TECH","relationship":"other investigation subject"},{"name":"Francisco Partners","relationship":"acquirer"},{"name":"Rocket Lab Corporation","relationship":"acquirer"},{"name":"Merck KGaA","relationship":"acquirer"}],"dollarAmounts":[{"amount":"$7.40","context":"per share cash offer for Weave Communications"},{"amount":"$27.00","context":"cash offer per share for Iridium Communications"},{"amount":"$73.00","context":"per share cash offer for Bio-Techne Corporation"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-24T19:12:02.051Z","global_importance":15,"audience_relevance":10,"importance_components":{"eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":null,"modelName":"glm-4.7"}}